Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No substantive changes detected between the old and new screenshots of the ClinicalTrials.gov study page; content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:08:55.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T09:21:55.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    New contact details and an updated revision version (v3.1.0) were added, replacing the previous v3.0.2.
    Difference
    0.0%
    Check dated 2025-09-28T03:07:28.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Update to v3.0.2 from v3.0.1 and removal of the Back to Top link; a small release update with a minor navigation change.
    Difference
    0.1%
    Check dated 2025-09-13T16:55:21.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T14:31:26.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names, locations, and a clinical trial for Tuspetinib in patients with relapsed or refractory acute myeloid leukemia, while also removing outdated information about previous trials and locations.
    Difference
    10%
    Check dated 2025-08-30T11:16:52.000Z thumbnail image

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.